Physician profile
Nu Chai
NPI 1073830477
$25,945.77
in general payments reported to CMS, 2019-2025
10 companies · $642 in 2025
The $642 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.63 · 2022: $280 · 2023: $21K · 2024: $4,232 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $17K · Travel and Lodging: $6,430 · Food and Beverage: $1,364 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $17,150.00 |
| Travel and Lodging | $6,430.42 |
| Food and Beverage | $1,363.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $675.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $24,793.43 | 2023-2024 | Qutenza |
| Biotronik Nro, INC. | $489.13 | 2024-2025 | Prospera |
| Bioventus LLC | $170.21 | 2022 | |
| Abbvie INC. | $129.41 | 2024-2025 | |
| Nevro Corp. | $109.56 | 2022 | |
| Tersera Therapeutics LLC | $64.43 | 2024 | Prialt |
| Mml US, INC. | $56.72 | 2025 | Reactiv8 |
| Stryker Corporation | $52.16 | 2025 | Mild Device Kit, Optablate |
| Boston Scientific Corporation | $46.63 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $34.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nu Chai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.